These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22997130)

  • 1. Joint modeling of hierarchically clustered and overdispersed non-gaussian continuous outcomes for comet assay data.
    Ghebretinsae AH; Faes C; Molenberghs G; Geys H; Van der Leede BJ
    Pharm Stat; 2012; 11(6):449-55. PubMed ID: 22997130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian, generalized frailty model for comet assays.
    Ghebretinsae AH; Faes C; Molenberghs G; De Boeck M; Geys H
    J Biopharm Stat; 2013 May; 23(3):618-36. PubMed ID: 23611199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A joint model for longitudinal continuous and time-to-event outcomes with direct marginal interpretation.
    Efendi A; Molenberghs G; Njagi EN; Dendale P
    Biom J; 2013 Jul; 55(4):572-88. PubMed ID: 23606452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A general approach for two-stage analysis of multilevel clustered non-Gaussian data.
    Chervoneva I; Iglewicz B; Hyslop T
    Biometrics; 2006 Sep; 62(3):752-9. PubMed ID: 16984317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multilevel model for hierarchical, repeated, and overdispersed time-to-event outcomes and its estimation strategies.
    Efendi A; Molenberghs G
    J Biopharm Stat; 2013; 23(6):1420-34. PubMed ID: 24138440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of multiple ordinal endpoints.
    Häberle L; Pfahlberg A; Gefeller O
    Biom J; 2009 Feb; 51(1):217-26. PubMed ID: 19197963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling longitudinal data, II: standard regression models and extensions.
    Ravani P; Barrett B; Parfrey P
    Methods Mol Biol; 2009; 473():61-94. PubMed ID: 19160732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-dimensional joint model for longitudinal outcomes of different nature.
    Faes C; Aerts M; Molenberghs G; Geys H; Teuns G; Bijnens L
    Stat Med; 2008 Sep; 27(22):4408-27. PubMed ID: 18551509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of an incomplete binary outcome derived from frequently recorded longitudinal continuous data: application to daily pain evaluation.
    Bunouf P; Grouin JM; Molenberghs G
    Stat Med; 2012 Jul; 31(15):1554-71. PubMed ID: 22359232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating co-primary endpoints collectively in clinical trials.
    Li QH
    Biom J; 2009 Feb; 51(1):137-45. PubMed ID: 19219905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-level models for repeated measurement data: application to quality of life data in clinical trials.
    Beacon HJ; Thompson SG
    Stat Med; 1996 Dec; 15(24):2717-32. PubMed ID: 8981682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hierarchical Binomial-Poisson model for the analysis of a crossover design for correlated binary data when the number of trials is dose-dependent.
    Shkedy Z; Molenberghs G; Van Craenendonck H; Steckler T; Bijnens L
    J Biopharm Stat; 2005; 15(2):225-39. PubMed ID: 15796291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling overdispersion in longitudinal count data in clinical trials with application to epileptic data.
    Fotouhi AR
    Contemp Clin Trials; 2008 Jul; 29(4):547-54. PubMed ID: 18308644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hierarchical bayesian model for spatial prediction of multivariate non-gaussian random fields.
    Chagneau P; Mortier F; Picard N; Bacro JN
    Biometrics; 2011 Mar; 67(1):97-105. PubMed ID: 20374239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical Bayesian modeling of heterogeneous cluster- and subject-level associations between continuous and binary outcomes in dairy production.
    Bello NM; Steibel JP; Tempelman RJ
    Biom J; 2012 Mar; 54(2):230-48. PubMed ID: 22522379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes.
    Galbraith S; Marschner IC
    Stat Med; 2003 Jun; 22(11):1787-805. PubMed ID: 12754715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint modeling of longitudinal and survival data via a common frailty.
    Ratcliffe SJ; Guo W; Ten Have TR
    Biometrics; 2004 Dec; 60(4):892-9. PubMed ID: 15606409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling heterogeneity in clustered count data with extra zeros using compound Poisson random effect.
    Ma R; Hasan MT; Sneddon G
    Stat Med; 2009 Aug; 28(18):2356-69. PubMed ID: 19462420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.